Does OZANIMOD Cause Basal cell carcinoma? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Basal cell carcinoma have been filed in association with OZANIMOD (ZEPOSIA 7-Day Starter Pack). This represents 0.1% of all adverse event reports for OZANIMOD.
10
Reports of Basal cell carcinoma with OZANIMOD
0.1%
of all OZANIMOD reports
0
Deaths
2
Hospitalizations
How Dangerous Is Basal cell carcinoma From OZANIMOD?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for OZANIMOD.
What Other Side Effects Does OZANIMOD Cause?
Fatigue (707)
Multiple sclerosis relapse (567)
Drug ineffective (517)
Headache (490)
Dizziness (329)
Product dose omission issue (325)
Nausea (267)
Diarrhoea (253)
Colitis ulcerative (246)
Pain (228)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which OZANIMOD Alternatives Have Lower Basal cell carcinoma Risk?
OZANIMOD vs PACLITAXEL
OZANIMOD vs PACRITINIB
OZANIMOD vs PALBOCICLIB
OZANIMOD vs PALIPERIDONE
OZANIMOD vs PALIVIZUMAB